The clinical effectiveness and cost-effectiveness of the PROGENSA® prostate cancer antigen 3 assay and the Prostate Health Index in the diagnosis of prostate cancer: a systematic review and economic evaluation.
Saved in:
| Title: | The clinical effectiveness and cost-effectiveness of the PROGENSA® prostate cancer antigen 3 assay and the Prostate Health Index in the diagnosis of prostate cancer: a systematic review and economic evaluation. |
|---|---|
| Authors: | Nicholson A; Liverpool Reviews and Implementation Group, University of Liverpool, Liverpool, UK., Mahon J; Liverpool Reviews and Implementation Group, University of Liverpool, Liverpool, UK., Boland A; Liverpool Reviews and Implementation Group, University of Liverpool, Liverpool, UK., Beale S; Liverpool Reviews and Implementation Group, University of Liverpool, Liverpool, UK., Dwan K; Liverpool Reviews and Implementation Group, University of Liverpool, Liverpool, UK., Fleeman N; Liverpool Reviews and Implementation Group, University of Liverpool, Liverpool, UK., Hockenhull J; Liverpool Reviews and Implementation Group, University of Liverpool, Liverpool, UK., Dundar Y; Liverpool Reviews and Implementation Group, University of Liverpool, Liverpool, UK. |
| Source: | Health technology assessment (Winchester, England) [Health Technol Assess] 2015 Oct; Vol. 19 (87), pp. i-xxxi, 1-191. |
| Publication Type: | Journal Article; Research Support, Non-U.S. Gov't; Systematic Review |
| Journal Info: | Publisher: NIHR Journals Library Country of Publication: England NLM ID: 9706284 Publication Model: Print Cited Medium: Internet ISSN: 2046-4924 (Electronic) Linking ISSN: 13665278 NLM ISO Abbreviation: Health Technol Assess Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
Be the first to leave a comment!
